Sinohealth Technology issues profit warning: 1H2026 net profit projected to plunge 73%–98% despite revenue growth

Bulletin Express07-29

Sinohealth Technology Holdings Limited (Sinohealth Technology) has released a profit warning for the six months ended 30 June 2026 (1H2026), citing foreign-exchange losses and higher research-and-development (R&D) spending as the main headwinds.

Preliminary unaudited figures indicate that revenue will rise to approximately RMB158.50 million–RMB164.50 million, up 7.20%–11.20% from RMB147.90 million recorded in the same period of 2025.

In contrast, net profit is expected to contract sharply to around RMB0.60 million–RMB6.60 million, down 73.06%–97.55% from RMB24.50 million in 1H2025. Management attributes the earnings decline to: 1) Exchange losses stemming from the depreciation of the US dollar against the renminbi, which eroded the value of the Group’s USD-denominated assets; and 2) Increased investment in R&D, including additional talent recruitment and development of AI-powered platforms aimed at strengthening long-term competitiveness.

The Board highlighted continued progress in expanding innovative data-driven businesses and reaffirmed the Group’s healthy cash position to support ongoing strategic initiatives.

These figures are based on management accounts that have not yet been audited or reviewed by the Company’s audit committee. Sinohealth Technology plans to publish its interim results by the end of August 2026. Shareholders and potential investors are advised to exercise caution when dealing in the Company’s securities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1126678008?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-29 19:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126678008","market":"us","top_or_hot":-1,"title":"Sinohealth Technology issues profit warning: 1H2026 net profit projected to plunge 73%–98% despite revenue growth","media":"Bulletin Express","content":"<p>Sinohealth Technology Holdings Limited (Sinohealth Technology) has released a profit warning for the six months ended 30 June 2026 (1H2026), citing foreign-exchange losses and higher research-and-development (R&D) spending as the main headwinds.</p>\n<p>Preliminary unaudited figures indicate that revenue will rise to approximately RMB158.50 million–RMB164.50 million, up 7.20%–11.20% from RMB147.90 million recorded in the same period of 2025.</p>\n<p>In contrast, net profit is expected to contract sharply to around RMB0.60 million–RMB6.60 million, down 73.06%–97.55% from RMB24.50 million in 1H2025. Management attributes the earnings decline to:  \n1) Exchange losses stemming from the depreciation of the US dollar against the renminbi, which eroded the value of the Group’s USD-denominated assets; and  \n2) Increased investment in R&D, including additional talent recruitment and development of AI-powered platforms aimed at strengthening long-term competitiveness.</p>\n<p>The Board highlighted continued progress in expanding innovative data-driven businesses and reaffirmed the Group’s healthy cash position to support ongoing strategic initiatives.</p>\n<p>These figures are based on management accounts that have not yet been audited or reviewed by the Company’s audit committee. Sinohealth Technology plans to publish its interim results by the end of August 2026. Shareholders and potential investors are advised to exercise caution when dealing in the Company’s securities.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sinohealth Technology issues profit warning: 1H2026 net profit projected to plunge 73%–98% despite revenue growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinohealth Technology issues profit warning: 1H2026 net profit projected to plunge 73%–98% despite revenue growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-29 19:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sinohealth Technology Holdings Limited (Sinohealth Technology) has released a profit warning for the six months ended 30 June 2026 (1H2026), citing foreign-exchange losses and higher research-and-development (R&D) spending as the main headwinds.</p>\n<p>Preliminary unaudited figures indicate that revenue will rise to approximately RMB158.50 million–RMB164.50 million, up 7.20%–11.20% from RMB147.90 million recorded in the same period of 2025.</p>\n<p>In contrast, net profit is expected to contract sharply to around RMB0.60 million–RMB6.60 million, down 73.06%–97.55% from RMB24.50 million in 1H2025. Management attributes the earnings decline to:  \n1) Exchange losses stemming from the depreciation of the US dollar against the renminbi, which eroded the value of the Group’s USD-denominated assets; and  \n2) Increased investment in R&D, including additional talent recruitment and development of AI-powered platforms aimed at strengthening long-term competitiveness.</p>\n<p>The Board highlighted continued progress in expanding innovative data-driven businesses and reaffirmed the Group’s healthy cash position to support ongoing strategic initiatives.</p>\n<p>These figures are based on management accounts that have not yet been audited or reviewed by the Company’s audit committee. Sinohealth Technology plans to publish its interim results by the end of August 2026. Shareholders and potential investors are advised to exercise caution when dealing in the Company’s securities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02361","symbol_name":"中康科技控股","start_time":0,"source_url":"","article_id":"1126678008","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126678008","pubTimestamp":1785325536,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sinohealth Technology Holdings Limited (Sinohealth Technology) has released a profit warning for the six months ended 30 June 2026 (1H2026), citing foreign-exchange losses and higher...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02361":"中康科技控股"},"translate_title":"中国健康科技发布盈利预警：尽管收入增长，2026年上半年净利润预计将暴跌73%-98%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02361":1},"content_text":"Sinohealth Technology Holdings Limited (Sinohealth Technology) has released a profit warning for the six months ended 30 June 2026 (1H2026), citing foreign-exchange losses and higher research-and-development (R&D) spending as the main headwinds.\nPreliminary unaudited figures indicate that revenue will rise to approximately RMB158.50 million–RMB164.50 million, up 7.20%–11.20% from RMB147.90 million recorded in the same period of 2025.\nIn contrast, net profit is expected to contract sharply to around RMB0.60 million–RMB6.60 million, down 73.06%–97.55% from RMB24.50 million in 1H2025. Management attributes the earnings decline to:  \n1) Exchange losses stemming from the depreciation of the US dollar against the renminbi, which eroded the value of the Group’s USD-denominated assets; and  \n2) Increased investment in R&D, including additional talent recruitment and development of AI-powered platforms aimed at strengthening long-term competitiveness.\nThe Board highlighted continued progress in expanding innovative data-driven businesses and reaffirmed the Group’s healthy cash position to support ongoing strategic initiatives.\nThese figures are based on management accounts that have not yet been audited or reviewed by the Company’s audit committee. Sinohealth Technology plans to publish its interim results by the end of August 2026. Shareholders and potential investors are advised to exercise caution when dealing in the Company’s securities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1126678008","isCrawlerRequest":true}